Doctor profile · Federal record
Dr. Ellen de Moll, MD
Dermatology Physician (CMS: Dermatology) · New Canaan, CT
- NPI 1518349877
- Accepts Medicare
- 11 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
38 East Ave
New Canaan, CT 068405516
(203) 200-0523
Credentials & registration
- NPI registered
- June 2015 — 11 yrs on file
- Profile last updated
- January 18, 2025
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Connecticut #64827
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1518349877. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,386
Distinct HCPCS
10
Medicare allowed
$96,441
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 315 | 227 | $95 | |
11102 |
Biopsy of related skin growth, first growth | 196 | 167 | $106 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 180 | 141 | $60 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 142 | 45 | $7 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 133 | 46 | $1 | |
17000 |
Destruction of precancer skin growth, 1 growth | 113 | 90 | $60 | |
11103 |
Biopsy of related skin growth, each additional growth | 83 | 55 | $55 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 59 | 59 | $119 | |
11900 |
Injection into skin growth, 1-7 growths | 51 | 38 | $54 | |
17110 |
Destruction of skin growth, 1-14 growths | 47 | 41 | $121 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 80. This provider delivers 17× the peer median.Open Payments
Industry payments received
All-time total
$23,087
Transactions
128
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Galderma Laboratories, L.P. | 27 | $20,673.66 | |
| Janssen Biotech, Inc. | 16 | $515.12 | |
| ABBVIE INC. | 21 | $500.56 | |
| Incyte Corporation | 12 | $299.41 | |
| Regeneron Healthcare Solutions, Inc. | 9 | $286.46 | |
| Lilly USA, LLC | 13 | $244.03 | |
| PFIZER INC. | 11 | $179.71 | |
| Novartis Pharmaceuticals Corporation | 4 | $87.09 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $73.20 | |
| GENZYME CORPORATION | 3 | $66.91 | |
| Dermavant Sciences, Inc. | 3 | $62.39 | |
| UCB, Inc. | 2 | $31.99 | |
| Merck Sharp & Dohme LLC | 1 | $28.54 | |
| Arcutis Biotherapeutics, Inc. | 1 | $22.74 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $14.71 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
650
Patients
399
Total drug cost
$127,967
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 106 | 78 | $1,752 |
| Ketoconazole | Generic | 95 | 53 | $1,627 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 69 | 45 | $2,510 |
| Clobetasol Propionate | Generic | 62 | 46 | $4,666 |
| Fluorouracil | Generic | 55 | 53 | $5,207 |
| Finasteride | Generic | 31 | 11 | $655 |
| Fluconazole | Generic | 31 | 21 | $750 |
| Prednisone | Generic | 31 | 16 | $205 |
| Minoxidil | Generic | 29 | 12 | $1,036 |
| Dupixent Pen (Dupilumab) | Brand | 26 | 0 | $104,188 |
Hospital affiliations
Frequently asked questions
What is Dr. Ellen de Moll's medical specialty?
Dr. Ellen de Moll practices Dermatology Physician in New Canaan, CT.
Where does Dr. Ellen de Moll practice?
Dr. Ellen de Moll practices at 38 East Ave, New Canaan, CT 068405516. Office phone: 2032000523.
What is Dr. Ellen de Moll's NPI?
Dr. Ellen de Moll's National Provider Identifier (NPI) is 1518349877, issued by NPPES.
Does Dr. Ellen de Moll accept Medicare assignment?
Yes. Dr. Ellen de Moll accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ellen de Moll commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Biopsy of related skin growth, first growth (HCPCS 11102); Established patient office or other outpatient visit (HCPCS 99212). Source: CMS Medicare Physician & Other Practitioners file.